Scholarlink

Background <p>Recent studies have shown that from the 23rd week of gestation onward, the fetus becomes progressively more hypoxic, with oxygenation levels rising again after 33–34 weeks. The biological significance of this biphasic oxygenation pattern has remained unclear.</p> Methods <p>Umbilical cord blood samples from 100 preterm and 100 full-term neonates were analyzed for blood gas parameters and for <i>HIF1A, ADRB3</i> (β3-adrenoceptor), and <i>VEGFA</i> gene expression.</p> Results <p>A progressive increase in mRNA expression of all three genes was observed with advancing gestational age, followed by a decline during the final weeks of pregnancy. This gene expression trend was inversely correlated with fetal oxygenation status.</p> Conclusion <p>This study demonstrates that β3-adrenoceptor expression progressively increases with gestational age, supporting the concept that this receptor plays a key role in fetal development and well-being. These findings strengthen the evidence from animal models showing that pharmacological activation of β3-adrenoceptors can reproduce, even after birth, some of the beneficial effects normally provided by the intrauterine environment. Collectively, this work supports the conceptual framework for developing a “pharmacological artificial placenta” aimed at mimicking intrauterine conditions to promote physiological neonatal adaptation.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>Recent studies have shown that from the 23rd week of gestation onward, the fetus becomes progressively more hypoxic, with oxygenation levels rising again after 33–34 weeks. However, the biological significance of this biphasic oxygenation pattern had remained unclear.</p> </ItemContent> <ItemContent> <p>This study demonstrates for the first time that fetal oxygen fluctuations are accompanied by a synchronous and coordinated increase in the mRNA expression of <i>HIF1A</i>, <i>ADRB3</i> (β3-adrenoceptor), and <i>VEGFA</i> genes.</p> </ItemContent> <ItemContent> <p>These findings support a mechanistic link between intrauterine hypoxia, β3-adrenergic signaling, and fetal maturation.</p> </ItemContent> <ItemContent> <p>This work contributes to ongoing research suggesting that pharmacological β3-adrenoceptor activation may help recreate intrauterine-like conditions, potentially promoting physiological fetal development in adverse environments.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

HIF1A, ADRB3, and VEGFA gene expression in human cord blood across gestation: insights toward a pharmacological artificial placenta

  • 期刊论文

  • 发表日期：

    2026年4月3日

查看全文
  • Rosa Teresa Scaramuzzo,
  • Lucrezia Filippini,
  • Maura Calvani,
  • Bianca Tirinnanzi,
  • Stefania Crucitta,
  • Marzia Del Re,
  • Riccardo Morganti,
  • Lorenza Di Marsico,
  • Maurizio Cammalleri,
  • Paola Bagnoli,
  • Massimo Dal Monte,
  • Alessandro Pini,
  • Luca Filippi

摘要

Background

Recent studies have shown that from the 23rd week of gestation onward, the fetus becomes progressively more hypoxic, with oxygenation levels rising again after 33–34 weeks. The biological significance of this biphasic oxygenation pattern has remained unclear.

Methods

Umbilical cord blood samples from 100 preterm and 100 full-term neonates were analyzed for blood gas parameters and for HIF1A, ADRB3 (β3-adrenoceptor), and VEGFA gene expression.

Results

A progressive increase in mRNA expression of all three genes was observed with advancing gestational age, followed by a decline during the final weeks of pregnancy. This gene expression trend was inversely correlated with fetal oxygenation status.

Conclusion

This study demonstrates that β3-adrenoceptor expression progressively increases with gestational age, supporting the concept that this receptor plays a key role in fetal development and well-being. These findings strengthen the evidence from animal models showing that pharmacological activation of β3-adrenoceptors can reproduce, even after birth, some of the beneficial effects normally provided by the intrauterine environment. Collectively, this work supports the conceptual framework for developing a “pharmacological artificial placenta” aimed at mimicking intrauterine conditions to promote physiological neonatal adaptation.

Impact

Recent studies have shown that from the 23rd week of gestation onward, the fetus becomes progressively more hypoxic, with oxygenation levels rising again after 33–34 weeks. However, the biological significance of this biphasic oxygenation pattern had remained unclear.

This study demonstrates for the first time that fetal oxygen fluctuations are accompanied by a synchronous and coordinated increase in the mRNA expression of HIF1A, ADRB3 (β3-adrenoceptor), and VEGFA genes.

These findings support a mechanistic link between intrauterine hypoxia, β3-adrenergic signaling, and fetal maturation.

This work contributes to ongoing research suggesting that pharmacological β3-adrenoceptor activation may help recreate intrauterine-like conditions, potentially promoting physiological fetal development in adverse environments.